YABAO PHARM.CORP released its semi-annual performance, with a net profit attributable to the parent company of 174 million yuan, a year-on-year decrease of 2.99%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, YABAO PHARM.CORP disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 1.139 billion yuan, a year-on-year decrease of 21.08%; the net profit attributable to shareholders of the listed company was 174 million yuan, a year-on-year decrease of 2.99%; the net profit excluding non-recurring gains and losses was 160 million yuan, a year-on-year decrease of 1.69%; the basic earnings per share were 0.2483 yuan
According to the Zhitong Finance APP, YABAO PHARM.CORP (600351.SH) disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 1.139 billion yuan, a year-on-year decrease of 21.08%; the net profit attributable to shareholders of the listed company was 174 million yuan, a year-on-year decrease of 2.99%; the net profit excluding non-recurring gains and losses was 160 million yuan, a year-on-year decrease of 1.69%; and the basic earnings per share were 0.2483 yuan